The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

ConditionsLeiomyoma (Uterine Fibroids)Adenomyoma of Uterus Uterine Bleeding

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorErkan Gol

About this trial

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Eligibility criteria

Qualifiers

Women aged ≥18 years

Planned total abdominal hysterectomy for benign indications

Sexually active within the last 4 weeks

Able to complete the Female Sexual Function Index (FSFI) questionnaire

Disqualifiers

Gynecologic malignancy

Major additional pelvic reconstructive surgery

Severe psychiatric or neurologic disorder

Inability to complete follow-up assessments

Trial design

Treatments tested in this trial

Uterine Manipulator
Conventional Abdominal Hysterectomy

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Erkan Gol

Lead sponsor

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Sponsor institution

Source ClinicalTrials.gov